182 related articles for article (PubMed ID: 35392571)
21. Intravesical injections of autologous platelet-rich plasma for the treatment of refractory interstitial cystitis.
Kuo HC
Low Urin Tract Symptoms; 2023 Nov; 15(6):210-215. PubMed ID: 37702275
[TBL] [Abstract][Full Text] [Related]
22. Early three-month report of amniotic bladder therapy in patients with interstitial cystitis/bladder pain syndrome.
Madan R; Radoiu C; Liaw A; Lucas S; Hamada A; Dhar N
Int Urol Nephrol; 2023 Aug; 55(8):1937-1942. PubMed ID: 37273012
[TBL] [Abstract][Full Text] [Related]
23. Intravesical Botulinum Toxin Injection Plus Hydrodistention Is More Effective in Patients with Bladder Pain-Predominant Interstitial Cystitis/Bladder Pain Syndrome.
Yu WR; Jhang JF; Kuo HC
Toxins (Basel); 2024 Feb; 16(2):. PubMed ID: 38393152
[TBL] [Abstract][Full Text] [Related]
24. The Tumor Necrosis Factor-α Level in Platelet-Rich Plasma Might Be Associated with Treatment Outcome in Patients with Interstitial Cystitis/Bladder Pain Syndrome or Recurrent Urinary Tract Infection.
Jhang JF; Jiang YH; Lin TY; Kuo HC
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203334
[TBL] [Abstract][Full Text] [Related]
25. Reliability and validity of Turkish versions of the interstitial cystitis symptom index and interstitial cystitis problem index.
Esen B; Obaid K; Süer E; Gökçe Mİ; Gökmen D; Bedük Y; Gülpınar Ö
Neurourol Urodyn; 2020 Nov; 39(8):2338-2343. PubMed ID: 32846036
[TBL] [Abstract][Full Text] [Related]
26. [A comparative analysis of intravesical sodium hyaluronate monotherapy and its combination with oral chondroitin sulfate in patietns with bladder pain syndrome/intersticial cystitis].
Aboyan IA; Aboyan VE; Pavlov SV; Zinkovskaya OV; Pavlov DS
Urologiia; 2019 Apr; (1):35-39. PubMed ID: 31184015
[TBL] [Abstract][Full Text] [Related]
27. Repeated onabotulinumtoxin-a injections provide better results than single injection in treatment of painful bladder syndrome.
Kuo HC
Pain Physician; 2013 Jan; 16(1):E15-23. PubMed ID: 23340540
[TBL] [Abstract][Full Text] [Related]
28. Bladder instillations vs onabotulinumtoxinA injection for interstitial cystitis/bladder pain syndrome: a randomized clinical trial.
Welch EK; Dengler KL; DiCarlo-Meacham AM; Wheat JE; Pekny CJ; Aden JK; Vaccaro CM
Am J Obstet Gynecol; 2024 May; ():. PubMed ID: 38768800
[TBL] [Abstract][Full Text] [Related]
29. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial.
Kuo HC; Jiang YH; Tsai YC; Kuo YC
Neurourol Urodyn; 2016 Jun; 35(5):609-14. PubMed ID: 25914337
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency.
Ke QS; Jhang JF; Lin TY; Ho HC; Jiang YH; Hsu YH; Kuo HC
Ci Ji Yi Xue Za Zhi; 2019; 31(3):135-143. PubMed ID: 31258287
[TBL] [Abstract][Full Text] [Related]
31. Intravesical Botulinum Toxin A Injections for Bladder Pain Syndrome/Interstitial Cystitis: A Systematic Review and Meta-Analysis of Controlled Studies.
Wang J; Wang Q; Wu Q; Chen Y; Wu P
Med Sci Monit; 2016 Sep; 22():3257-67. PubMed ID: 27624897
[TBL] [Abstract][Full Text] [Related]
32. Treatment Outcomes of Intravesical Botulinum Toxin A Injections on Patients with Interstitial Cystitis/Bladder Pain Syndrome.
Yu WR; Jiang YH; Jhang JF; Chang WC; Kuo HC
Toxins (Basel); 2022 Dec; 14(12):. PubMed ID: 36548768
[TBL] [Abstract][Full Text] [Related]
33. A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome.
Bosch PC
Eur Urol; 2018 Nov; 74(5):623-630. PubMed ID: 30072210
[TBL] [Abstract][Full Text] [Related]
34. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis.
Gülpınar Ö; Esen B; Kayış A; Gökçe Mİ; Süer E
Neurourol Urodyn; 2018 Jan; 37(1):257-262. PubMed ID: 28480984
[TBL] [Abstract][Full Text] [Related]
35. Botulinum Neurotoxin A Intravesical Injections in Interstitial Cystitis/Bladder Painful Syndrome: A Systematic Review with Meta-Analysis.
Giannantoni A; Gubbiotti M; Bini V
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31480323
[TBL] [Abstract][Full Text] [Related]
36. Factors associated with treatment outcomes after intravesical hyaluronic acid therapy in women with refractory interstitial cystitis: A prospective, multicenter study.
Tsai CP; Yang JM; Liang SJ; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Hung MJ
J Chin Med Assoc; 2021 Apr; 84(4):418-422. PubMed ID: 33784267
[TBL] [Abstract][Full Text] [Related]
37. Liposomal bladder instillations for IC/BPS: an open-label clinical evaluation.
Peters KM; Hasenau D; Killinger KA; Chancellor MB; Anthony M; Kaufman J
Int Urol Nephrol; 2014 Dec; 46(12):2291-5. PubMed ID: 25209396
[TBL] [Abstract][Full Text] [Related]
38. A Novel Intravesical Dextrose Injection Improves Lower Urinary Tract Symptoms on Interstitial Cystitis/Bladder Pain Syndrome.
Chen CL; Kao CC; Yang MH; Fan GY; Cherng JH; Tsao CW; Wu ST; Cha TL; Meng E
Front Pharmacol; 2021; 12():755615. PubMed ID: 34975473
[TBL] [Abstract][Full Text] [Related]
39. Predictive Factors for a Satisfactory Treatment Outcome with Intravesical Botulinum Toxin A Injection in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
Wang HJ; Yu WR; Ong HL; Kuo HC
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31752328
[TBL] [Abstract][Full Text] [Related]
40. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
Chuang YC; Kuo HC
J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
